AINMF (NetraMark Holdings) Moat Score: 2/10 (As of Jun. 30, 2026)


AINMF NetraMark Holdings Inc AINMF
22 GF Score
Price $0.43
GF Value $0.21
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is NetraMark Holdings Moat Score?

NetraMark Holdings AINMF +3.10% 22 Moat Score is 2 as of Jun. 30, 2026. GuruFocus rates AINMF with a GF Score™ of 22/100 and a GF Value™ of $0.21 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 678 Healthcare Providers & Services companies, NetraMark Holdings ranks better than 79.35% on this metric.

NetraMark Holdings has the Moat Score of 2, which implies that the company might have No Moat - Very weak/transient advantages.

NetraMark Holdings has No Moat: NetraMark Holdings Inc lacks significant market leadership or customer switching costs. The company does not have a strong brand or durable cost advantages, and there are no significant regulatory barriers or exclusive licenses. Its intellectual property and innovation capabilities are not sufficient to establish a competitive edge.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes NetraMark Holdings might have No Moat - Very weak/transient advantages.

NetraMark Holdings  (OTCPK:AINMF) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

NetraMark Holdings Moat Score Related Terms

AINMF vs VEEV, BTSG, TEM: Moat Score Comparison

For the Health Information Services subindustry, NetraMark Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NetraMark Holdings Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where NetraMark Holdings's Moat Score falls into.


AINMF
22GF Score
NetraMark Holdings Inc AINMF
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 2 mean?
NetraMark Holdings (AINMF) has a Moat Score of 2 as of Jun. 30, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, NetraMark Holdings ranks #140 out of 678 companies in the Healthcare Providers & Services industry, placing it in the top 20.6%.
Is NetraMark Holdings' Moat Score too high?
NetraMark Holdings' current Moat Score is 2. Based on the distribution chart, NetraMark Holdings ranks #140 out of 678 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, NetraMark Holdings has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NetraMark Holdings' Moat Score compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NetraMark Holdings ranks #140 out of 678 companies for Moat Score. This places NetraMark Holdings in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. NetraMark Holdings's current Moat Score is 2. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NetraMark Holdings stock overvalued right now?
Based on GuruFocus' analysis, NetraMark Holdings (AINMF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.21, compared to a current price of $0.43 — trading 106.4% above its estimated fair value. The current Moat Score is 2. NetraMark Holdings' overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For NetraMark Holdings (AINMF), the current Moat Score is 2 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NetraMark Holdings (AINMF) Overvalued in 2026?

Based on GuruFocus' analysis, NetraMark Holdings stock appears to be overvalued. The current stock price of $0.43 is trading 106.4% above its estimated GF Value™ of $0.21. GuruFocus considers NetraMark Holdings to be Significantly Overvalued.

Key valuation signals for AINMF:

  • Moat Score: 2
  • GF Value™: $0.21 vs. price of $0.43 (106.4% above fair value)
  • GF Score™: 22/100 with 2 warning signs

No single metric tells the full story. See the AINMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NetraMark Holdings Business Description

Other Exchanges PF0:GermanyAIAI:Canada
Address 1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1
NetraMark Holdings Inc provides AI-powered insights and software solutions to optimize clinical trial design and outcomes for pharmaceutical sponsors. The company offers AI solutions to trial sponsors, CROs, and biotechnology companies across the globe. It earns revenue from its proprietary NetraAI platform, an advanced machine learning system purpose-built to analyze complex clinical trial data and identify meaningful patient subpopulations.
22GF Score

Get the complete analysis for AINMF

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.43
Price
$0.21
GF Value